ArticleACS pharmacology & translational science2023

First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer.

Yibin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.